NSC-118,994

Known as: NSC-118994 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1975-1981
01219751981

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1981
Review
1981
All Phase II studies with diglycoaldehyde with leukemia and solid tumors have been reviewed. The dose schedules employed ranged… (More)
Is this relevant?
1978
1978
The effects of the anticancer drug diglycolaldehyde (NSC-118994) were studied on Chinese hamster ovary cells growing in vitro… (More)
Is this relevant?
1976
1976
Inosine dialdehyde (IdA), a new antitumor agent presently undergoing clinical evaluation in man, possesses two aldehyde groups… (More)
Is this relevant?
1976
1976
The pharmacologic disposition of inosine dialdehyde (IdA) was studied in mice, rats, dogs, and monkeys. 14C-IdA was utilized to… (More)
Is this relevant?
1975
1975
An initial clinical phase I trial of inosine dialdehyde has been carried out in 40 patients at dose levels of 30-4000 mg/m2 for 5… (More)
Is this relevant?
1975
1975
Inosine dialdehyde, an antitumor agent highly active against several murine tumors, ispresently undergoing clinical trial for… (More)
Is this relevant?